QuidelOrtho Corporation (NASDAQ:QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that its board of directors has authorized the repurchase of up to $300 million of shares of QuidelOrtho’s common stock over the next two years.
Tesla, Upstart, Airbnb, Nu Holdings, Taiwan Semiconductor: Why These 5 Stocks Are Drawing Investors’ Attention Today
Major Wall Street indices closed in the red after the consumer price index released on Tuesday showed inflation increased 0.5% in January, with an annual gain of 6.4%, against the consensus estimate of 6.2%.
